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Background
According guidelines, patients with coronary artery disease
(CAD) should undergo revascularization if myocardial
ischemia is present. While coronary angiography (CXA)
allows the morphological assessment of CAD, the
fractional flow reserve (FFR) has proved to be a comple-
mentary invasive test to assess the functional severity of
CAD, i.e. to detect ischemia. Perfusion Cardiac Magnetic
Resonance (CMR) has emerged as a robust non-invasive
technique to assess myocardial ischemia. The goal of the
study was to compare the cost-effectiveness ratio - defined
as the costs per patient correctly diagnosed - of two
algorithms used to diagnose hemodynamically significant
CAD in relation to the pretest likelihood of CAD: 1) a
CMR to assess ischemia before referring positive patients
to CXA (CMR+CXA), 2) a CXA in all patients combined
with a FFR test in patients with angiographically positive
stenoses (CXA+FFR).
Methods
The costs, evaluated from the health care system
perspective in the Swiss, German, United Kingdom
(UK), and the United States (US) contexts, included
public prices of the different tests considered as outpati-
ent procedures, complications’ costs and costs induced
by diagnosis errors (false negative). The effectiveness
criterion was the ability to accurately identify a patient
with significant, i.e. hemodynamically relevant CAD.
Test performances used in the model were based on
clinical literature. Using a mathematical model, we com-
pared the cost-effectiveness ratio for both algorithms for
hypothetical patient cohorts with different pretest likeli-
hood of CAD.
Results
The cost-effectiveness ratio decreased hyperbolically with
increasing pretest likelihood of CAD for both strategies.
CMR+CXA and CXA+FFR were equally cost-effective at a
pretest likelihood of CAD of 62% in Switzerland, 65% in
Germany, 83% in the UK, and 84% in the US with costs of
CHF 5’793, € 1’517, £ 2’683, and $ 2’128 per patient cor-
rectly diagnosed. Below these thresholds, CMR+CXA
showed lower costs per patient correctly diagnosed than
CXA+FFR.
Conclusions
Implications for the health care system/professionals/
patients/society The CMR+CXA strategy is more cost-
effective than CXA+FFR below a CAD prevalence of
62%, 65%, 83%, and 84% for the Swiss, the German, the
UK, and the US health care systems, respectively. These
findings may help to optimize resource utilization in the
diagnosis of coronary artery disease. They show to what
extent the cost-effectiveness to diagnose CAD depends
on the prevalence of the disease.
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